{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-078761","form_type":"8-K","ticker":"RVP","cik":"0000946563","company_name":"RETRACTABLE TECHNOLOGIES INC","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.753141+00:00","generated_at":"2026-05-17T13:49:35.548399+00:00","sec_items":["8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Retractable Technologies Q2 net sales up 73% to $10.4M, operating loss narrows to $5.1M","bullets":["Net sales $10.4M in Q2 2025 (+73% YoY); operating loss narrowed to $5.1M from $5.8M.","H1 2025 net sales $18.7M (+37.5% YoY); operating loss widened to $9.8M from $8.7M.","Tariffs: 130% on Chinese needles/syringes; $2.1M spent on tariffs in H1 2025.","Shifted 38% of production to U.S. facility (vs 9% in H1 2024); workforce reductions implemented.","Received $1.9M litigation settlement in May; Q2 net loss only $87K due to investment gains."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-078761","json":"https://secwatch.observer/filing/0001104659-25-078761.json","markdown":"https://secwatch.observer/filing/0001104659-25-078761.md","text":"https://secwatch.observer/filing/0001104659-25-078761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946563/000110465925078761/0001104659-25-078761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946563/000110465925078761/tm2523459d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:49:35.548399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}